Mohammad S Siddiqui
Overview
Explore the profile of Mohammad S Siddiqui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
57
Citations
1582
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Gries J, Lazarus J, Brennan P, Siddiqui M, Targher G, Lang C, et al.
Lancet Gastroenterol Hepatol
. 2024 Dec;
10(1):82-94.
PMID: 39674228
Metabolic dysfunction-associated steatotic liver disease (MASLD) has emerged as a public health threat as it affects approximately 38% of the adult population worldwide, with its prevalence rising in step with...
2.
Satapathy S, Elwir S, Brandman D, Smith C, Jiang Y, Vanatta J, et al.
Transplantation
. 2024 Oct;
109(3):484-495.
PMID: 39434206
Background: Chronic kidney disease (CKD) is a well-recognized complication in patients undergoing liver transplantation (LT), particularly those with metabolic dysfunction-associated steatohepatitis (MASH), a leading cause of cirrhosis in the modern...
3.
Bhati C, Kirkman D, Forsgren M, Kamal H, Khan H, Boyett S, et al.
JGH Open
. 2024 Sep;
8(9):e70024.
PMID: 39318868
Background And Aim: Quantification of body compartments, particularly the interaction between adipose tissue and skeletal muscle, is emerging as novel a biomarker of metabolic health. The present study evaluated the...
4.
Yasin A, Nguyen M, Sidhu A, Majety P, Spitz J, Asgharpour A, et al.
Diabetes Res Clin Pract
. 2024 Apr;
211:111650.
PMID: 38604447
The incidence and prevalence of metabolic syndrome (MetS) and type 2 diabetes mellitus (T2DM) are rising globally. MetS and T2DM are associated with significant morbidity and mortality, which is partly...
5.
Lee E, Anand V, Razavi A, Alebna P, Muthiah M, Siddiqui M, et al.
Curr Cardiol Rep
. 2024 Feb;
26(4):199-210.
PMID: 38376745
Purpose Of Review: The objective of this manuscript is to examine the current literature on the epidemiology of metabolic dysfunction-associated steatotic liver disease (MASLD), its correlation with cardiovascular disease (CVD)...
6.
Jain V, Mehta A, Lee T, Liu C, Chew N, Ko Y, et al.
J Am Heart Assoc
. 2023 Dec;
12(24):e031230.
PMID: 38063161
Background: Literature suggests a bidirectional association between advanced hepatic fibrosis (AHF) and coronary artery disease (CAD). We evaluated the association of AHF with immune activation, systemic inflammation, and adverse outcomes...
7.
Mehta A, Lee T, Alebna P, Grandhi G, Dixon D, Salloum F, et al.
J Clin Lipidol
. 2023 Nov;
17(6):828-833.
PMID: 37957050
Nonalcoholic fatty liver disease (NAFLD) is associated with atherogenic dyslipidemia and an increased risk of cardiovascular events. Previous studies have suggested an inverse relationship between NAFLD severity and lipoprotein(a) [Lp(a)]...
8.
Xiao J, Ng C, Chan K, Fu C, Tay P, Yong J, et al.
J Clin Exp Hepatol
. 2023 Jul;
13(4):656-665.
PMID: 37440949
Background: Non-alcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver disease globally. While the prevalence, impact, and causes of mortality have been described in various meta-analyses, a systematic...
9.
Ng C, Chan K, Muthiah M, Tan C, Tay P, Lim W, et al.
Hepatology
. 2023 Jan;
77(5):1712-1721.
PMID: 36645228
Background And Aims: Fatty liver is the commonest liver condition globally and traditionally associated with NAFLD. A consensus meeting was held in Chicago to explore various terminologies. Herein, we explore...
10.
Fagan A, Gavis E, Gallagher M, Mousel T, Davis B, Puri P, et al.
J Hepatol
. 2022 Sep;
78(2):312-321.
PMID: 36152764
Background & Aims: Even after recovery from overt hepatic encephalopathy (HE), minimal HE (MHE), which impairs quality of life (QoL), can persist. A double-blind, placebo-controlled randomized clinical trial was performed...